Repare Therapeutics Inc.
NASDAQ:RPTX
3.58 (USD) • At close November 4, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets: | ||||||||||||||||||||
Current Assets: | ||||||||||||||||||||
Cash & Cash Equivalents
| 79.82 | 103.217 | 111.268 | 107.369 | 115.544 | 121.461 | 159.521 | 155.191 | 275.834 | 305.136 | 334.427 | 260.995 | 293.635 | 311.399 | 326.184 | 347.872 | 369.933 | 83.711 | 94.797 | -10.731 |
Short Term Investments
| 128.303 | 133.784 | 112.359 | 142.703 | 165.148 | 192.663 | 184.42 | 215.162 | 6.255 | 6.528 | 7.439 | 7.194 | 7.16 | 7.497 | 7.526 | 0 | 0 | 0 | 0 | 21.462 |
Cash and Short Term Investments
| 208.123 | 237.001 | 223.627 | 250.072 | 280.692 | 314.124 | 343.941 | 370.353 | 282.089 | 311.664 | 341.866 | 268.189 | 300.795 | 318.896 | 333.71 | 347.872 | 369.933 | 83.711 | 94.797 | 10.731 |
Net Receivables
| 14.643 | 14.206 | 15.312 | 19.47 | 7.032 | 7.013 | 4.323 | 14.609 | 4.407 | 3.649 | 3.234 | 3.084 | 6.264 | 5.432 | 6.164 | 4.869 | 4.035 | 3.399 | 3.056 | 0 |
Inventory
| 0 | 0 | 0 | -15.739 | -1.751 | 0 | -2.805 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Current Assets
| 5.773 | 3.463 | 4.749 | 21.29 | 5.952 | 4.389 | 8.52 | 5.635 | 3.242 | 3.915 | 6.314 | 9.103 | 2.129 | 3.882 | 6.678 | 8.524 | 3.296 | 0.775 | 0.719 | 0 |
Total Current Assets
| 228.539 | 254.67 | 243.688 | 275.093 | 291.925 | 325.526 | 353.979 | 390.597 | 289.738 | 319.228 | 351.414 | 280.376 | 309.188 | 328.21 | 346.552 | 361.265 | 377.264 | 87.885 | 98.572 | 10.731 |
Non-Current Assets: | ||||||||||||||||||||
Property, Plant & Equipment, Net
| 5.421 | 6.477 | 7.541 | 8.605 | 9.255 | 10.372 | 9.599 | 10.587 | 11.58 | 12.4 | 13.095 | 11.418 | 8.866 | 8.769 | 8.622 | 8.268 | 3.182 | 3.11 | 3.424 | 0 |
Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.218 | -0.215 | 0 | 0 | 0 | 0 | 0 | 0 |
Long Term Investments
| 1.077 | 1.63 | 2.276 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.218 | 0.215 | 0 | 0 | 0 | 0 | 0 | 0 |
Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7.477 | 6.229 | 4.935 | 3.62 | 2.843 | 2.038 | 1.586 | 1.412 | 0.218 | 0.192 | 0.132 | 0.132 | 0 |
Other Non-Current Assets
| 0.307 | 0.307 | 0.396 | 2.709 | 0.408 | 0.408 | 0.497 | 0.497 | 0.497 | 0.586 | 0.586 | 1.008 | 0.341 | 0.288 | 0.5 | 0.491 | 1.093 | 2.442 | 0.567 | -10.731 |
Total Non-Current Assets
| 6.805 | 8.414 | 10.213 | 11.314 | 9.663 | 10.78 | 10.096 | 18.561 | 18.306 | 17.921 | 17.301 | 15.269 | 11.463 | 10.858 | 10.534 | 8.977 | 4.467 | 5.684 | 4.123 | -10.731 |
Total Assets
| 235.344 | 263.084 | 253.901 | 286.407 | 301.588 | 336.306 | 364.075 | 409.158 | 308.044 | 337.149 | 368.715 | 295.645 | 320.651 | 339.068 | 357.086 | 370.242 | 381.731 | 93.569 | 102.695 | 0 |
Liabilities & Equity: | ||||||||||||||||||||
Current Liabilities: | ||||||||||||||||||||
Account Payables
| 7.182 | 6.825 | 2.4 | 5.438 | 4.893 | 3.62 | 0.461 | 9.345 | 4.991 | 1.546 | 2.302 | 1.86 | 3.303 | 3.352 | 2.251 | 1.843 | 3.576 | 3.294 | 2.127 | 0 |
Short Term Debt
| 1.957 | 2.218 | 2.4 | 2.333 | 2.32 | 2.257 | 2.171 | 2.127 | 2.135 | 1.857 | 1.721 | 1.458 | 0.758 | 0.568 | 0.697 | 0.794 | 0.608 | 0.626 | 0.625 | 0 |
Tax Payables
| 0 | 0 | 0 | 0 | 0 | 4.856 | 1.24 | 0 | 0 | 1.87 | 0.523 | 0.147 | 0.062 | 0.03 | 0.018 | 0.483 | 0.351 | 0.271 | 0.218 | 0 |
Deferred Revenue
| 0 | 1.073 | 10.222 | 20.472 | 24.412 | 52.76 | 53.102 | 34.784 | 11.855 | 11.874 | 11.921 | 8.925 | 8.763 | 2.081 | 2.073 | 2.15 | 58.142 | 0.271 | 1.49 | 0 |
Other Current Liabilities
| 22.31 | 20.454 | 24.057 | 20.729 | 21.628 | 22.298 | 22.885 | 15.615 | 20.459 | 18.806 | 19.145 | 11.167 | 10.399 | 6.419 | 5.993 | 5.406 | -52.529 | 3.116 | 0.004 | 0 |
Total Current Liabilities
| 31.449 | 30.57 | 39.079 | 48.972 | 53.253 | 80.935 | 78.619 | 61.871 | 39.44 | 34.083 | 35.089 | 23.41 | 23.223 | 12.42 | 11.014 | 10.193 | 9.797 | 7.307 | 4.246 | 0 |
Non-Current Liabilities: | ||||||||||||||||||||
Long Term Debt
| 0.218 | 0.561 | 1.01 | 1.591 | 2.226 | 2.78 | 3.257 | 3.767 | 4.495 | 5.154 | 5.592 | 5.623 | 3.54 | 3.235 | 3.308 | 3.259 | 0.136 | 0.258 | 0.439 | 0 |
Deferred Revenue Non-Current
| 0 | 0 | 1.73 | 2.476 | 0.695 | 1.347 | 2.682 | 37.744 | 38.592 | 39.252 | 39.613 | 48.359 | 48.799 | 55.76 | 55.934 | 55.992 | 58.142 | 8.142 | 8.142 | 0 |
Deferred Tax Liabilities Non-Current
| 0 | 0 | -1.73 | -2.476 | -0.695 | -1.347 | -2.682 | -37.744 | -38.592 | -39.252 | -39.613 | -48.359 | -48.799 | -55.76 | -55.934 | -55.992 | -58.142 | 0 | 0 | 0 |
Other Non-Current Liabilities
| -0 | 0 | 1.73 | 2.476 | 0.695 | 1.347 | 2.682 | 0 | 38.592 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 58.142 | 135.997 | 135.997 | 0 |
Total Non-Current Liabilities
| 0.218 | 0.561 | 2.74 | 4.067 | 2.921 | 4.127 | 5.939 | 41.511 | 43.087 | 44.406 | 45.205 | 53.982 | 52.339 | 58.995 | 59.242 | 59.251 | 58.278 | 144.397 | 144.578 | 0 |
Total Liabilities
| 31.667 | 31.131 | 41.819 | 53.039 | 56.174 | 85.062 | 84.558 | 103.382 | 82.527 | 78.489 | 80.294 | 77.392 | 75.562 | 71.415 | 70.256 | 69.444 | 68.075 | 151.704 | 148.824 | 0 |
Equity: | ||||||||||||||||||||
Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 135.997 | 135.997 | 31.873 |
Common Stock
| 486.375 | 486.375 | 483.35 | 483.184 | 482.739 | 482.677 | 482.032 | 481.782 | 481.38 | 481.048 | 480.699 | 385.99 | 385.454 | 384.61 | 384.313 | 383.852 | 383.818 | 0.521 | 0.001 | 0 |
Retained Earnings
| -354.721 | -319.947 | -333.109 | -305.079 | -286.2 | -274.254 | -239.313 | -207.655 | -283.116 | -245.023 | -210.266 | -181.976 | -151.084 | -124.775 | -103.358 | -88.095 | -74.344 | -62.542 | -49.941 | 0 |
Accumulated Other Comprehensive Income/Loss
| -0.134 | -0.113 | 0.028 | -0.252 | -0.424 | -0.235 | -0.428 | -0.524 | 0 | 0 | -0 | -0 | 0 | 0 | 0 | 0 | 0 | -135.997 | -1.096 | -22.384 |
Other Total Stockholders Equity
| 72.157 | 65.638 | 61.813 | 55.515 | 49.299 | 43.056 | 37.226 | 32.173 | 27.253 | 22.635 | 17.988 | 14.239 | 10.719 | 7.818 | 5.875 | 5.041 | 4.182 | -132.111 | -131.09 | 0 |
Total Shareholders Equity
| 203.677 | 231.953 | 212.082 | 233.368 | 245.414 | 251.244 | 279.517 | 305.776 | 225.517 | 258.66 | 288.421 | 218.253 | 245.089 | 267.653 | 286.83 | 300.798 | 313.656 | -58.135 | -46.129 | 9.489 |
Total Equity
| 203.677 | 231.953 | 212.082 | 233.368 | 245.414 | 251.244 | 279.517 | 305.776 | 225.517 | 258.66 | 288.421 | 218.253 | 245.089 | 267.653 | 286.83 | 300.798 | 313.656 | -58.135 | -46.129 | 9.489 |
Total Liabilities & Shareholders Equity
| 235.344 | 263.084 | 253.901 | 286.407 | 301.588 | 336.306 | 364.075 | 409.158 | 308.044 | 337.149 | 368.715 | 295.645 | 320.651 | 339.068 | 357.086 | 370.242 | 381.731 | 93.569 | 102.695 | 9.489 |